Minocycline Protects Against Oxidative Stress in a Model of Maple Syrup Urine Disease
Neurochemical Research · 2025
DOI: 10.1007/s11064-025-04549-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, 2025. Verfasst von Isabela da Silva Lemos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Doenças Neurometabólicas, Programa de Pós-Graduação Em Ciências da Saúde, Universidade Do Extremo Sul Catarinense, Criciúma, SC, 88806…. Hauptthemen laut MEDLINE: Maple Syrup Urine Disease, Minocycline, Oxidative Stress. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Branched-chain amino acids (BCAA) leucine, isoleucine, and valine are metabolized by complex branched-chain ketoacids dehydrogenase (BCKDH). In Maple Syrup Urine Disease (MSUD), the BCKDH complex has its activity blocked by a genetic mutation, compromising the BCAA metabolism and leading to the accumulation of these BCAA, related to neurological damage in this disease. Thus, minocycline is a broad-spectrum antibiotic, bacteriostatic, and studies have shown benefits in neurodegenerative disease progression, like reduction of oxidative stress, inflammation, and downregulation of molecular pathways, such as apoptosis. Therefore, we make the hypothesis that the minocycline can ameliorate oxidative stress in the MSUD model. For this, we used 7-day-old male rats, who were treated with BCAA (leucine 393.42 mg/kg, isoleucine 121.66 mg/kg and valine 126.4 mg/kg) or saline solution (0,9%) subcutaneously, water, or minocycline (50 mg/kg) via gavage. Our results show that the MSUD group presents an increase in DCFH oxidation and TBARS levels, as well as a decrease in sulfhydryl content, related to oxidative species production, lipid and protein damage, and minocycline treatment rescues this damage found. In antioxidant activity, we found an increase in SOD activity also, a decrease in CAT in all groups studied compared to the control group. So, our results present positive effects of minocycline in MSUD, showing a potential use in this disease; moreover, more studies are necessary to understand the role of this molecule in this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Doenças Neurometabólicas, Programa de Pós-Graduação Em Ciências da Saúde, Universidade Do Extremo Sul Catarinense, Criciúma, SC, 88806-000, Brazil.
- Laboratório de Fisiopatologia Experimental, Programa de Pós-Graduação Em Ciências da Saúde, Universidade Do Extremo Sul Catarinense, Criciúma, SC, 88806-000, Brazil.
- Laboratório de Neurologia Experimental, Programa de Pós-Graduação Em Ciências da Saúde, Universidade Do Extremo Sul Catarinense, Criciúma, SC, 88806-000, Brazil.
- Laboratório de Doenças Neurometabólicas, Programa de Pós-Graduação Em Ciências da Saúde, Universidade Do Extremo Sul Catarinense, Criciúma, SC, 88806-000, Brazil. emiliostreck@gmail.com.
Zitieren
APA
da Silva Lemos, I., Seldenreich, R. F., Alano, C. G., Schmitt, L. Q., Matiola, R. T., De Pieri, E., Petronilho, F., Machado-De-Ávila, R. A., & Streck, E. L. (2025). Minocycline Protects Against Oxidative Stress in a Model of Maple Syrup Urine Disease. Neurochemical Research. https://doi.org/10.1007/s11064-025-04549-x
Vancouver
da Silva Lemos I, Seldenreich RF, Alano CG, Schmitt LQ, Matiola RT, De Pieri E, et al. Minocycline Protects Against Oxidative Stress in a Model of Maple Syrup Urine Disease. Neurochemical Research. 2025. doi:10.1007/s11064-025-04549-x
BibTeX
@article{daSilvaLemos2025,
author = {da Silva Lemos, Isabela and Seldenreich, Rejane Figueiredo and Alano, Carolina Giassi and Schmitt, Laura Quinsani and Matiola, Rafaela Tezza and De Pieri, Ellen and Petronilho, Fabricia and Machado-De-Ávila, Ricardo Andrez and Streck, Emilio Luiz},
title = {Minocycline Protects Against Oxidative Stress in a Model of Maple Syrup Urine Disease},
journal = {Neurochemical Research},
year = {2025},
doi = {10.1007/s11064-025-04549-x}
}
EUVIMED